Efavirenz, emtricitabine, and tenofovir and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Efavirenz, emtricitabine, and tenofovir and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: efavirenz / emtricitabine / tenofovir
Brand name: Atripla
Synonyms: Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Efavirenz, emtricitabine, and tenofovir-Insulin glargine, recombinant Subcutaneous
- Efavirenz, emtricitabine, and tenofovir-Insulin glulisine
- Efavirenz, emtricitabine, and tenofovir-Insulin Glulisine (Cartridges and Pens)
- Efavirenz, emtricitabine, and tenofovir-Insulin Glulisine (Vials)
- Efavirenz, emtricitabine, and tenofovir-Insulin glulisine Subcutaneous
- Efavirenz, emtricitabine, and tenofovir-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate
- Insulin glargine and lixisenatide Subcutaneous-Efavirenz, lamivudine, and tenofovir
- Insulin glargine and lixisenatide Subcutaneous-Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate
- Insulin glargine and lixisenatide Subcutaneous-Effaclor Duo
- Insulin glargine and lixisenatide Subcutaneous-Effer-K
- Insulin glargine and lixisenatide Subcutaneous-Effer-K Tablets